Carolin Reiser
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
-
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Jörg Kleeff (6 shared papers)Markus W. Büchler (6 shared papers)Helmut Frieß (5 shared papers)Iréne Esposito (4 shared papers)Ulf Hinz (3 shared papers)Thomas Giese (3 shared papers)Mert Erkan (3 shared papers)Nathalia A. Giese (2 shared papers)
- Journals
- Annals of Surgery (2 papers)Annals of Surgical Oncology (1 paper)Journal of Translational Medicine (1 paper)Digestion (1 paper)Gastroenterology (1 paper)
- Partner nations
- GermanySwitzerlandItaly
In The Last Decade
Carolin Reiser
7 papers receiving 734 citations
Peers
Comparison fields: 5 of 70
- Oncology 585
- Cancer Research 135
- Pulmonary and Respiratory Medicine 200
- Surgery 243
- Hepatology 40
Countries citing papers authored by Carolin Reiser
This map shows the geographic impact of Carolin Reiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolin Reiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolin Reiser more than expected).
Fields of papers citing papers by Carolin Reiser
This network shows the impact of papers produced by Carolin Reiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolin Reiser. The network helps show where Carolin Reiser may publish in the future.
Co-authors
The 23 scholars most cited alongside Carolin Reiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 262 | |
| 2 | 2007 | 195 | |
| 3 | 2006 | 177 | |
| 4 | Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells. | 2006 | 47 |
| 5 | 2007 | 32 | |
| 6 | 2007 | 22 | |
| 7 | 2007 | 10 |
About Carolin Reiser
Carolin Reiser is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Cellular and Molecular Neuroscience, having authored 7 papers that have together received 745 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Pancreatitis Pathology and Treatment (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Abdominal vascular conditions and treatments (1 paper), Cell death mechanisms and regulation (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Gallbladder and Bile Duct Disorders (1 paper). The work is most often cited by research in Oncology (585 citations), Cancer Research (135 citations), Pulmonary and Respiratory Medicine (200 citations), Surgery (243 citations) and Hepatology (40 citations). Carolin Reiser has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Jörg Kleeff, Markus W. Büchler, Helmut Frieß, Iréne Esposito, Ulf Hinz, Thomas Giese, Mert Erkan, Nathalia A. Giese, Helmut Friess and Shailesh V. Shrikhande. Their work appears in journals such as Annals of Surgery, Annals of Surgical Oncology, Journal of Translational Medicine, Digestion and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.